In most patients with type 2 diabetes, chronic insulin treatment and use of sulphonylureas induce weight gain [16, 17], while metformin treatment has been consistently associated with modest weight loss [18, 19]. This evidence concerns the gene INS and type 2 diabetes mellitus.